Connection

Nichole Tanner to Lung Neoplasms

This is a "connection" page, showing publications Nichole Tanner has written about Lung Neoplasms.
Connection Strength

11.834
  1. An Evaluation of Annual Adherence to Lung Cancer Screening in a Large National Cohort. Am J Prev Med. 2022 08; 63(2):e59-e64.
    View in: PubMed
    Score: 0.421
  2. Guideline-Recommended Lung Cancer Screening Adherence Is Superior With a?Centralized Approach. Chest. 2022 03; 161(3):818-825.
    View in: PubMed
    Score: 0.406
  3. Mediastinal Staging for Lung Cancer. Chest. 2021 10; 160(4):1552-1559.
    View in: PubMed
    Score: 0.397
  4. Assessment of Integrated Classifier's Ability to Distinguish Benign From Malignant Lung Nodules: Extended Analyses and 2-Year Follow-Up Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial. Chest. 2021 03; 159(3):1283-1287.
    View in: PubMed
    Score: 0.382
  5. Improving Inequities in Lung Cancer Screening: Risk Prediction Models and the Potential to Achieve a Great Equalizer Effect. J Thorac Oncol. 2020 11; 15(11):1711-1713.
    View in: PubMed
    Score: 0.381
  6. Association of Cigarette Type and Nicotine Dependence in Patients Presenting for Lung Cancer Screening. Chest. 2020 11; 158(5):2184-2191.
    View in: PubMed
    Score: 0.373
  7. Screening Adherence in the Veterans Administration Lung Cancer Screening Demonstration Project. Chest. 2020 10; 158(4):1742-1752.
    View in: PubMed
    Score: 0.370
  8. Lung Cancer Screening: Patient Selection and Implementation. Clin Chest Med. 2020 03; 41(1):87-97.
    View in: PubMed
    Score: 0.365
  9. Association of Cigarette Type With Lung Cancer Incidence and Mortality: Secondary Analysis of the National Lung Screening Trial. JAMA Intern Med. 2019 12 01; 179(12):1710-1712.
    View in: PubMed
    Score: 0.358
  10. Effect of a Rule-in Biomarker Test on Pulmonary Nodule Management: A Survey of Pulmonologists and Thoracic Surgeons. Clin Lung Cancer. 2020 03; 21(2):e89-e98.
    View in: PubMed
    Score: 0.347
  11. In-person and Telephonic Shared Decision-making Visits for People Considering Lung Cancer Screening: An Assessment of Decision Quality. Chest. 2019 01; 155(1):236-238.
    View in: PubMed
    Score: 0.336
  12. Shared Decision-making and Lung Cancer Screening: Let's Get the Conversation Started. Chest. 2019 01; 155(1):21-24.
    View in: PubMed
    Score: 0.332
  13. Standard Bronchoscopy With Fluoroscopy vs Thin Bronchoscopy and Radial Endobronchial Ultrasound for Biopsy of Pulmonary Lesions: A Multicenter, Prospective, Randomized Trial. Chest. 2018 11; 154(5):1035-1043.
    View in: PubMed
    Score: 0.328
  14. Reviewing Lung Cancer Screening: The Who, Where, When, Why, and How. Clin Chest Med. 2018 03; 39(1):31-43.
    View in: PubMed
    Score: 0.317
  15. Assessing the Generalizability of the National Lung Screening Trial: Comparison of Patients with Stage 1 Disease. Am J Respir Crit Care Med. 2017 09 01; 196(5):602-608.
    View in: PubMed
    Score: 0.307
  16. Invasive Mediastinal Staging in Lung Cancer. Use a Prediction Model or Just Do It? Am J Respir Crit Care Med. 2017 06 15; 195(12):1556-1558.
    View in: PubMed
    Score: 0.302
  17. Chronic Obstructive Pulmonary Disease as a Lung Cancer Risk: Worth Its Weight in "GOLD". Ann Am Thorac Soc. 2017 03; 14(3):309-310.
    View in: PubMed
    Score: 0.296
  18. Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation. Chest. 2017 08; 152(2):263-270.
    View in: PubMed
    Score: 0.294
  19. Primary Care Provider and Patient Perspectives on Lung Cancer Screening. A Qualitative Study. Ann Am Thorac Soc. 2016 11; 13(11):1977-1982.
    View in: PubMed
    Score: 0.289
  20. The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial. Am J Respir Crit Care Med. 2016 Mar 01; 193(5):534-41.
    View in: PubMed
    Score: 0.276
  21. Management of Pulmonary Nodules by Community Pulmonologists: A Multicenter Observational Study. Chest. 2015 Dec; 148(6):1405-1414.
    View in: PubMed
    Score: 0.272
  22. Racial Differences in Outcomes within the National Lung Screening Trial. Implications for Widespread Implementation. Am J Respir Crit Care Med. 2015 Jul 15; 192(2):200-8.
    View in: PubMed
    Score: 0.265
  23. Screening for Lung Cancer Using Low-Dose Computed Tomography. Are We Headed for DANTE's Paradise or Inferno? Am J Respir Crit Care Med. 2015 May 15; 191(10):1100-1.
    View in: PubMed
    Score: 0.261
  24. Screening and early detection efforts in lung cancer. Cancer. 2015 May 01; 121(9):1347-56.
    View in: PubMed
    Score: 0.256
  25. Convex probe endobronchial ultrasound. Semin Respir Crit Care Med. 2014 Dec; 35(6):636-44.
    View in: PubMed
    Score: 0.253
  26. Attitudes and beliefs toward lung cancer screening among US Veterans. Chest. 2013 Dec; 144(6):1783-1787.
    View in: PubMed
    Score: 0.236
  27. Simultaneously diagnosing and staging lung cancer: a win-win for the patient and the health-care system. Chest. 2013 Dec; 144(6):1747-1749.
    View in: PubMed
    Score: 0.236
  28. New testing for lung cancer screening. Oncology (Williston Park). 2012 Feb; 26(2):176-82.
    View in: PubMed
    Score: 0.208
  29. The role of molecular analyses in the era of personalized therapy for advanced NSCLC. Lung Cancer. 2012 May; 76(2):131-7.
    View in: PubMed
    Score: 0.206
  30. An up to date look at lung cancer screening. Cell Adh Migr. 2010 Jan-Mar; 4(1):96-9.
    View in: PubMed
    Score: 0.181
  31. Research Priorities for Interventions to Address Health Disparities in Lung Nodule Management: An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2023 03 15; 207(6):e31-e46.
    View in: PubMed
    Score: 0.113
  32. Characteristics of Persons Screened for Lung Cancer in the United States : A Cohort Study. Ann Intern Med. 2022 Nov; 175(11):1501-1505.
    View in: PubMed
    Score: 0.109
  33. Factors Associated With Smoking Cessation Attempts in Lung Cancer Screening: A Secondary Analysis of the National Lung Screening Trial. Chest. 2023 02; 163(2):433-443.
    View in: PubMed
    Score: 0.109
  34. Tobacco Treatment Specialist Training for Lung Cancer Screening Providers. Am J Prev Med. 2021 11; 61(5):765-768.
    View in: PubMed
    Score: 0.100
  35. Addressing Disparities in Lung Cancer Screening Eligibility and Healthcare Access. An Official American Thoracic Society Statement. Am J Respir Crit Care Med. 2020 10 01; 202(7):e95-e112.
    View in: PubMed
    Score: 0.095
  36. Occurrence of Discussion about Lung Cancer Screening Between Patients and Healthcare Providers in the USA, 2017. J Cancer Educ. 2020 08; 35(4):678-681.
    View in: PubMed
    Score: 0.094
  37. Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report. Chest. 2020 07; 158(1):406-415.
    View in: PubMed
    Score: 0.092
  38. Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report. J Am Coll Radiol. 2020 Jul; 17(7):845-854.
    View in: PubMed
    Score: 0.092
  39. Management of Lung Nodules and Lung Cancer Screening During the COVID-19 Pandemic: CHEST Expert Panel Report. Radiol Imaging Cancer. 2020 05; 2(3):e204013.
    View in: PubMed
    Score: 0.092
  40. An Evaluation of Diagnostic Yield From Bronchoscopy: The Impact of Clinical/Radiographic Factors, Procedure Type, and Degree of Suspicion for Cancer. Chest. 2020 06; 157(6):1656-1664.
    View in: PubMed
    Score: 0.090
  41. Safely and Effectively Evaluating Computed Tomography-detected Lung Lesions. Much Work to Be Done. Ann Am Thorac Soc. 2019 11; 16(11):1360-1362.
    View in: PubMed
    Score: 0.089
  42. Incorporating Coexisting Chronic Illness into Decisions about Patient Selection for Lung Cancer Screening. An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2018 07 15; 198(2):e3-e13.
    View in: PubMed
    Score: 0.081
  43. Tobacco Dependence Predicts Higher Lung Cancer and Mortality Rates and Lower Rates of Smoking Cessation in the National Lung Screening Trial. Chest. 2018 07; 154(1):110-118.
    View in: PubMed
    Score: 0.081
  44. Comparison of Observed Harms and Expected Mortality Benefit for Persons in the Veterans Health Affairs Lung Cancer Screening Demonstration Project. JAMA Intern Med. 2018 03 01; 178(3):426-428.
    View in: PubMed
    Score: 0.079
  45. Assessment of Plasma Proteomics Biomarker's Ability to Distinguish Benign From Malignant Lung Nodules: Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial. Chest. 2018 09; 154(3):491-500.
    View in: PubMed
    Score: 0.079
  46. Underuse of Chest Radiography Versus Computed Tomography for Lung Cancer Screening. Am J Public Health. 2017 08; 107(8):1248-1250.
    View in: PubMed
    Score: 0.076
  47. Comparing Pulmonary Nodule Location During Electromagnetic Bronchoscopy With Predicted Location on the Basis of Two Virtual Airway Maps at Different Phases of?Respiration. Chest. 2018 01; 153(1):181-186.
    View in: PubMed
    Score: 0.076
  48. Racial and Ethnic Disparities in Early-Stage Lung Cancer Survival. Chest. 2017 09; 152(3):587-597.
    View in: PubMed
    Score: 0.075
  49. Implementation of Lung Cancer Screening in the Veterans Health Administration. JAMA Intern Med. 2017 03 01; 177(3):399-406.
    View in: PubMed
    Score: 0.074
  50. Viewing All the Trees in the Forest: The Importance of Reporting Abnormal Findings on CT Scan When Screening for Lung Cancer. Chest. 2017 03; 151(3):525-526.
    View in: PubMed
    Score: 0.074
  51. Evaluations of Implementation at Early-Adopting Lung Cancer Screening Programs: Lessons Learned. Chest. 2017 07; 152(1):70-80.
    View in: PubMed
    Score: 0.074
  52. Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial. Ann Am Thorac Soc. 2016 09; 13(9):1568-74.
    View in: PubMed
    Score: 0.072
  53. An official American Thoracic Society/American College of Chest Physicians policy statement: implementation of low-dose computed tomography lung cancer screening programs in clinical practice. Am J Respir Crit Care Med. 2015 Oct 01; 192(7):881-91.
    View in: PubMed
    Score: 0.067
  54. Reply: Lung Cancer Screening: The Balance between Harm and Benefit. Am J Respir Crit Care Med. 2015 May 15; 191(10):1209-10.
    View in: PubMed
    Score: 0.065
  55. Lung cancer screening. Am J Respir Crit Care Med. 2015 Jan 01; 191(1):19-33.
    View in: PubMed
    Score: 0.064
  56. Factors that influence physician decision making for indeterminate pulmonary nodules. Ann Am Thorac Soc. 2014 Dec; 11(10):1586-91.
    View in: PubMed
    Score: 0.063
  57. Assessing the usefulness of 18F-fluorodeoxyglucose PET-CT scan after stereotactic body radiotherapy for early-stage non-small cell lung cancer. Chest. 2014 Aug; 146(2):406-411.
    View in: PubMed
    Score: 0.062
  58. Response. Chest. 2014 Aug; 146(2):e70.
    View in: PubMed
    Score: 0.062
  59. The utility of nodule volume in the context of malignancy prediction for small pulmonary nodules. Chest. 2014 Mar 01; 145(3):464-472.
    View in: PubMed
    Score: 0.060
  60. Diagnostic approach to the solitary pulmonary nodule. Semin Respir Crit Care Med. 2013 Dec; 34(6):762-9.
    View in: PubMed
    Score: 0.059
  61. Physician preferences for management of patients with stage IIIA NSCLC: impact of bulk of nodal disease on therapy selection. J Thorac Oncol. 2012 Feb; 7(2):365-9.
    View in: PubMed
    Score: 0.052
  62. Using endobronchial ultrasound features to predict lymph node metastasis in patients with lung cancer. Chest. 2011 Dec; 140(6):1550-1556.
    View in: PubMed
    Score: 0.050
  63. Lung cancer: progress in diagnosis, staging and therapy. Respirology. 2010 Jan; 15(1):44-50.
    View in: PubMed
    Score: 0.045
  64. The use of convex probe endobronchial ultrasound-guided transbronchial needle aspiration in a pediatric population: a multicenter study. Pediatr Pulmonol. 2014 Aug; 49(8):807-15.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.